Actively Recruiting
Using Low-Intensity Focused Ultrasound to Study Brain Circuits and Negative Emotions in Treatment-Resistant Depression in Adults 18 to 65
Led by Laureate Institute for Brain Research, Inc. · Updated on 2026-03-02
140
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying treatment-resistant Major Depressive Disorder MDD, a condition affecting about one third of people with depression who do not respond well to typical treatments and suffer from severe symptoms like anhedonia and rumination. This study aims to understand how brain circuits related to Negative Valence Systems contribute to these symptoms by using low-intensity focused ultrasound LIFU to modulate deep brain connections non-invasively. The goal is to better define brain targets that could lead to improved neuromodulation therapies for this population in need of new treatments. The study will involve 120 participants with treatment-resistant depression who will receive either LIFU targeting deep white matter tracts connecting the thalamus to the orbitofrontal cortex OFC or anterior cingulate cortex ACC, or a sham placebo stimulation. Each ultrasound treatment consists of an 80-second train of 20-millisecond bursts delivered non-invasively. The targets are personalized using advanced brain imaging to match each participants anatomy. The trial uses a randomized, triple-blind design with two experimental arms and one sham comparator. Participants will undergo brain scans including resting-state functional MRI before and up to 30 minutes after sonication or sham intervention. Behavioral assessments will measure reward processing and rumination to explore changes related to the ultrasound treatment. The main outcomes include changes in brain connectivity and behavior after sonication. The study includes monitoring of symptoms, safety, and adherence, with participation lasting through the immediate post-treatment assessment period. This research aims to clarify brain-behavior links and inform future precision neuromodulation strategies in depression.
CONDITIONS
Brief Title
Ultrasound Neuromodulation of Circuits and Negative Valence Systems in Treatment-Resistant Depression
Research Team
S
Salvador M Guinjoan, MD, PhD
D
Danielle E Clark, MA
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here